Corporate News
Gräfelfing, July 18, 2025 – PharmaSGP Holding SE (ISIN: DE000A2P4LJ5 WKN: A2P4LJ) announces that the public delisting tender offer made by FUTRUE GmbH to the shareholders of PharmaSGP is open for acceptance.
Shareholders of PharmaSGP can tender their shares under the delisting tender offer in exchange for a cash consideration of €28.00 per PharmaSGP share until August 11, 2025 at 24:00 hours (CEST).
The offer document as well as a non-binding English translation of the offer document are available online at https://www.futrue-offer.com.
No comments:
Post a Comment